Log in to save to my catalogue

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6d9d2c41c5a7421e8e623af43f06aa5e

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

About this item

Full title

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

Publisher

England: BioMed Central

Journal title

Alzheimer's research & therapy, 2019-09, Vol.11 (1), p.78-78, Article 78

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

In vivo, high cerebral amyloid-β load has been associated with (i) reduced concentrations of Aβ
in cerebrospinal fluid and (ii) increased retention using amyloid-β positron emission tomography. Although these two amyloid-β biomarkers generally show good correspondence, ~ 10-20% of cases have discordant results. To assess the consequences of havi...

Alternative Titles

Full title

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6d9d2c41c5a7421e8e623af43f06aa5e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6d9d2c41c5a7421e8e623af43f06aa5e

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-019-0532-x

How to access this item